Clearance of atypical cutaneous manifestations of hyper-IgE syndrome with dupilumab. Nihal A, Comstock JR, Holland KE, Singh AM, et al. Pediatr Dermatol 2022;39:940-942.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Nihal A, Comstock JR, Holland KE, Singh AM, et al. Clearance of atypical cutaneous manifestations of hyper-IgE syndrome with dupilumab. Pediatr Dermatol 2022;39:940-942.
PMID: 35734823